Litcius/Paper detail

Casimersen: First Approval

Matt Shirley

2021Drugs278 citationsDOI

Topics & Concepts

Exon skippingDuchenne muscular dystrophyMedicineDystrophinExonAntisense therapyMorpholinoClinical trialOrphan drugGenetic enhancementBioinformaticsInternal medicineGeneGeneticsOligonucleotideBiologyAlternative splicingLocked nucleic acidZebrafishMuscle Physiology and DisordersProsthetics and Rehabilitation RoboticsCardiomyopathy and Myosin Studies
Casimersen: First Approval | Litcius